Uncategorized
Latest content
- Winning takes more than innovation – it requires an ecosystem ready to adopt it
- DEBRA Research joins with Topadur to advance therapies for dystrophic epidermolysis bullosa
- Eli Lilly names Ilya Yuffa as executive vice president and president, Lilly Global Markets
- Novartis presents positive results from two phase 3 trials for relapsing MS
- MHRA approves new oral treatment for moderate-to-severe plaque psoriasis
Latest intelligence
- Who’s steering? Why pharma needs humans at the helm of AI
- The impact of AI and digital health on chronic diseases
- Regulatory complexity: the challenges of navigating the new normal
- From ambition to action: realising the true value of health
- Strengthening engagement with HCPs needs deep understanding not digital bombardment




